• Je něco špatně v tomto záznamu ?

Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts

Š. Novák, M. Kolář, A. Szabó, Z. Vernerová, L. Lacina, H. Strnad, J. Šáchová, M. Hradilová, J. Havránek, M. Španko, M. Čoma, L. Urban, M. Kaňuchová, N. Melegová, R. Gürlich, J. Dvořák, K. Smetana, P. Gál, P. Szabo

. 2021 ; 18 (3) : 221-243. [pub] -

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004379

BACKGROUND/AIM: Pancreatic ductal adenocarcinoma (PDAC) still represents one of the most aggressive cancers. Understanding of the epithelial-mesenchymal crosstalk as a crucial part of the tumor microenvironment should pave the way for therapies to improve patient survival rates. Well-established cell lines present a useful and reproducible model to study PDAC biology. However, the tumor-stromal interactions between cancer cells and cancer-associated fibroblasts (CAFs) are still poorly understood. MATERIALS AND METHODS: We studied interactions between four PDAC cell lines (Panc-1, CAPAN-2, MIAPaCa-2, and PaTu-8902) and conditioned media derived from primary cultures of normal fibroblasts/PDAC-derived CAFs (PANFs). RESULTS: When the tested PDAC cell lines were stimulated by PANF-derived conditioned media, the most aggressive behavior was acquired by the Panc-1 cell line (increased number and size of colonies, remaining expression of vimentin and keratin 8 as well as increase of epithelial-to-mesenchymal polarization markers), whereas PaTu-8902 cells were rather inhibited. Of note, administration of the conditioned media to MIAPaCa-2 cells resulted in an inverse effect on the size and number of colonies, whereas CAPAN-2 cells were rather stimulated. To explain the heterogeneous pattern of the observed PDAC crosstalk at the in vitro level, we further compared the phenotype of primary cultures of cells derived from ascitic fluid with that of the tested PDAC cell lines, analyzed tumor samples of PDAC patients, and performed gene expression profiling of PANFs. Immuno-cyto/histo-chemical analysis found specific phenotype differences within the group of examined patients and tested PDAC cell lines, whereas the genomic approach in PANFs found the key molecules (IL6, IL8, MFGE8 and periostin) that may contribute to the cancer aggressive behavior. CONCLUSION: The desmoplastic patient-specific regulation of cancer cells by CAFs (also demonstrated by the heterogeneous response of PDAC cell lines to fibroblasts) precludes simple targeting and development of an effective treatment strategy and rather requires establishment of an individualized tumor-specific treatment protocol.

BIOCEV 1st Faculty of Medicine Charles University Vestec Czech Republic

Department of Biomedical Research East Slovak Institute of Cardiovascular Diseases Košice Slovak Republic

Department of Dermatology and Venereology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Informatics and Chemistry Faculty of Chemical Technology University of Chemistry and Technology Prague Czech Republic

Department of Oncology 1st Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Otorhinolaryngology Head and Neck Surgery 1st Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Pathology 3rd Faculty of Medicine Charles University and University Hospital Královske Vinohrady Prague Czech Republic

Department of Pharmacology Pavol Jozef Šafárik University Košice Slovak Republic

Department of Stomatology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Surgery 3rd Faculty of Medicine Charles University and University Hospital Královske Vinohrady Prague Czech Republic

Institute of Anatomy 1st Faculty of Medicine Charles University Prague Czech Republic

Laboratory of Cell Interactions Center of Clinical and Preclinical Research MediPark Pavol Jozef Šafárik University Košice Slovak Republic

Laboratory of Genomics and Bioinformatics Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Prague Burn Centre 3rd Faculty of Medicine Charles University and University Hospital Královske Vinohrady Prague Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004379
003      
CZ-PrNML
005      
20240716102308.0
007      
ta
008      
220113s2021 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/cgp.20254 $2 doi
035    __
$a (PubMed)33893076
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Novák, Štepán $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Otorhinolaryngology, Head and Neck Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
245    10
$a Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts / $c Š. Novák, M. Kolář, A. Szabó, Z. Vernerová, L. Lacina, H. Strnad, J. Šáchová, M. Hradilová, J. Havránek, M. Španko, M. Čoma, L. Urban, M. Kaňuchová, N. Melegová, R. Gürlich, J. Dvořák, K. Smetana, P. Gál, P. Szabo
520    9_
$a BACKGROUND/AIM: Pancreatic ductal adenocarcinoma (PDAC) still represents one of the most aggressive cancers. Understanding of the epithelial-mesenchymal crosstalk as a crucial part of the tumor microenvironment should pave the way for therapies to improve patient survival rates. Well-established cell lines present a useful and reproducible model to study PDAC biology. However, the tumor-stromal interactions between cancer cells and cancer-associated fibroblasts (CAFs) are still poorly understood. MATERIALS AND METHODS: We studied interactions between four PDAC cell lines (Panc-1, CAPAN-2, MIAPaCa-2, and PaTu-8902) and conditioned media derived from primary cultures of normal fibroblasts/PDAC-derived CAFs (PANFs). RESULTS: When the tested PDAC cell lines were stimulated by PANF-derived conditioned media, the most aggressive behavior was acquired by the Panc-1 cell line (increased number and size of colonies, remaining expression of vimentin and keratin 8 as well as increase of epithelial-to-mesenchymal polarization markers), whereas PaTu-8902 cells were rather inhibited. Of note, administration of the conditioned media to MIAPaCa-2 cells resulted in an inverse effect on the size and number of colonies, whereas CAPAN-2 cells were rather stimulated. To explain the heterogeneous pattern of the observed PDAC crosstalk at the in vitro level, we further compared the phenotype of primary cultures of cells derived from ascitic fluid with that of the tested PDAC cell lines, analyzed tumor samples of PDAC patients, and performed gene expression profiling of PANFs. Immuno-cyto/histo-chemical analysis found specific phenotype differences within the group of examined patients and tested PDAC cell lines, whereas the genomic approach in PANFs found the key molecules (IL6, IL8, MFGE8 and periostin) that may contribute to the cancer aggressive behavior. CONCLUSION: The desmoplastic patient-specific regulation of cancer cells by CAFs (also demonstrated by the heterogeneous response of PDAC cell lines to fibroblasts) precludes simple targeting and development of an effective treatment strategy and rather requires establishment of an individualized tumor-specific treatment protocol.
650    _2
$a fibroblasty asociované s nádorem $x metabolismus $x patologie $7 D000072645
650    _2
$a duktální karcinom slinivky břišní $x metabolismus $x patologie $7 D021441
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a epitelo-mezenchymální tranzice $7 D058750
650    _2
$a fibroblasty $x metabolismus $x patologie $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a nádory slinivky břišní $x metabolismus $x patologie $7 D010190
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kolář, Michal $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Szabó, Arpád $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Královske Vinohrady, Prague, Czech Republic
700    1_
$a Vernerová, Zdena $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Královske Vinohrady, Prague, Czech Republic
700    1_
$a Lacina, Lukáš $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $u Department of Dermatology and Venereology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Strnad, Hynek $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Šáchová, Jana $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Hradilová, Miluše $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Havránek, Jan $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague, Czech Republic
700    1_
$a Španko, Michal $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Stomatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Čoma, Matúš $u Department of Pharmacology, Pavol Jozef Šafárik University, Košice, Slovak Republic $u Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic
700    1_
$a Urban, Lukáš $u Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic $u Laboratory of Cell Interactions, Center of Clinical and Preclinical Research MediPark, Pavol Jozef Šafárik University, Košice, Slovak Republic
700    1_
$a Kaňuchová, Miriam $u Laboratory of Cell Interactions, Center of Clinical and Preclinical Research MediPark, Pavol Jozef Šafárik University, Košice, Slovak Republic
700    1_
$a Melegová, Nikola $u Laboratory of Cell Interactions, Center of Clinical and Preclinical Research MediPark, Pavol Jozef Šafárik University, Košice, Slovak Republic
700    1_
$a Gürlich, Robert $u Department of Surgery, Third Faculty of Medicine, Charles University and University Hospital Královske Vinohrady, Prague, Czech Republic
700    1_
$a Dvořák, Josef $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
700    1_
$a Smetana, Karel $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
700    1_
$a Gál, Peter, $u Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic; pavol.szabo@lf1.cuni.cz pgal@vusch.sk galovci@yahoo.com $u Laboratory of Cell Interactions, Center of Clinical and Preclinical Research MediPark, Pavol Jozef Šafárik University, Košice, Slovak Republic $u Prague Burn Centre, Third Faculty of Medicine, Charles University and University Hospital Královske Vinohrady, Prague, Czech Republic $d 1981- $7 xx0320027
700    1_
$a Szabo, Pavol $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic; pavol.szabo@lf1.cuni.cz pgal@vusch.sk galovci@yahoo.com $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $u Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Košice, Slovak Republic
773    0_
$w MED00180194 $t Cancer genomics & proteomics $x 1790-6245 $g Roč. 18, č. 3 (2021), s. 221-243
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33893076 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20240716102305 $b ABA008
999    __
$a ok $b bmc $g 1751745 $s 1155528
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 18 $c 3 $d 221-243 $e - $i 1790-6245 $m Cancer genomics & proteomics $n Cancer Genomics Proteomics $x MED00180194
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...